We observed a significant decrease in tumor size, suggesting that TRIM27 is essential for TNBC tumor growth in vivo and that inhibition of the ZNF165 transcriptional complex may be a promising avenue of therapeutic intervention (Figure 6H and I). The gene discussed is TRIM27; the disease is neoplasm.